S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture

Innate Pharma (IPHA) News Today

$2.66
+0.06 (+2.31%)
(As of 02/23/2024 ET)
SourceHeadline
businesswire.com logoInnate Pharma Announces Its Participation to Upcoming Investor Conference
businesswire.com - February 21 at 1:00 AM
marketbeat.com logoInnate Pharma (NASDAQ:IPHA) Trading Up 0.4%
marketbeat.com - January 30 at 1:35 AM
finance.yahoo.com logoNumber of Shares and Voting Rights of Innate Pharma as of January 1, 2024
finance.yahoo.com - January 12 at 1:59 AM
finanznachrichten.de logoInnate Pharma SA: Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
finanznachrichten.de - January 4 at 2:17 AM
finanznachrichten.de logoInnate Pharma SA: Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
finanznachrichten.de - January 4 at 2:17 AM
finance.yahoo.com logoInnate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
finance.yahoo.com - January 4 at 2:17 AM
marketbeat.com logoInnate Pharma S.A. (NASDAQ:IPHA) Short Interest Update
marketbeat.com - January 3 at 8:44 AM
seekingalpha.com logoIPHYF Innate Pharma S.A.
seekingalpha.com - December 31 at 3:21 PM
morningstar.com logoInnate Pharma SA ADR
morningstar.com - December 19 at 8:31 PM
msn.com logoInnate Pharma CEO Mahjoubi to leave company
msn.com - December 18 at 12:41 PM
benzinga.com logoInnate Pharma Stock (NASDAQ:IPHA), Analyst Ratings, Price Targets, Predictions
benzinga.com - December 1 at 10:00 AM
benzinga.com logoInnate Pharma Stock (NASDAQ:IPHA) Dividends: History, Yield and Dates
benzinga.com - December 1 at 10:00 AM
markets.businessinsider.com logoPromising Clinical Outcomes and Strategic Partnerships Reinforce Buy Rating for Innate Pharma
markets.businessinsider.com - November 17 at 3:31 AM
markets.businessinsider.com logoPromising Updates on Lacutamab and ANKET Portfolio Fuel Buy Rating for Innate Pharma’s Stock
markets.businessinsider.com - November 16 at 8:50 PM
finance.yahoo.com logoInnate Pharma S.A. (NASDAQ:IPHA) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 15 at 1:20 PM
finance.yahoo.com logoInnate Pharma Reports Third Quarter 2023 Financial Results and Business Update
finance.yahoo.com - November 14 at 2:27 AM
finance.yahoo.com logoNumber of Shares and Voting Rights of Innate Pharma as of October 3, 2023
finance.yahoo.com - October 9 at 8:43 AM
businesswire.com logoInnate Pharma Announces Encore Presentation of Interim Results of Phase 2 TELLOMAK Study With Lacutamab With Updated Olsen 2022 Criteria at the EORTC Cutaneous Lymphoma Tumour ...
businesswire.com - October 7 at 1:55 PM
finance.yahoo.com logoInnate Pharma Provides Update on Lacutamab Clinical Program
finance.yahoo.com - October 5 at 1:46 AM
marketbeat.com logoInnate Pharma S.A. (NASDAQ:IPHA) Short Interest Down 8.1% in August
marketbeat.com - September 19 at 7:21 AM
finance.yahoo.com logoInnate Pharma Reports First Half 2023 Financial Results and Business Update
finance.yahoo.com - September 14 at 2:14 AM
finance.yahoo.com logoInnate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update
finance.yahoo.com - August 29 at 2:06 AM
finance.yahoo.com logoInnate Pharma S.A. (IPHA)
finance.yahoo.com - August 9 at 3:28 PM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Innate Pharma (IPHA)
markets.businessinsider.com - June 16 at 7:26 AM
finance.yahoo.com logoInnate Pharma Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study With Updated Olsen Criteria
finance.yahoo.com - June 16 at 2:25 AM
finance.yahoo.com logoInnate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma
finance.yahoo.com - June 12 at 12:59 PM
finance.yahoo.com logoInnate Pharma Highlights Proprietary Tetra-specific ANKET® NK Cell Engager IPH6501 at the EHA 2023 Congress
finance.yahoo.com - June 10 at 2:04 AM
finance.yahoo.com logoWhy Shares of Innate Pharma Jumped Thursday
finance.yahoo.com - June 8 at 2:35 PM
finance.yahoo.com logoNumber of Shares and Voting Rights of Innate Pharma as of June 1, 2023
finance.yahoo.com - June 7 at 3:30 AM
finance.yahoo.com logoOutcome of Innate Pharma’s 2023 Annual General Meeting
finance.yahoo.com - May 12 at 5:54 PM
finance.yahoo.com logoNumber of shares and voting rights of Innate Pharma as of May 1, 2023
finance.yahoo.com - May 9 at 2:04 AM
finance.yahoo.com logoNumber of Shares and Voting Rights of Innate Pharma as of April 1, 2023
finance.yahoo.com - April 18 at 1:54 AM
finance.yahoo.com logoInnate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023
finance.yahoo.com - April 7 at 2:40 AM
finance.yahoo.com logoInnate Pharma S.A. (NASDAQ:IPHA) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 27 at 8:12 AM
marketbeat.com logoInnate Pharma (NASDAQ:IPHA) Rating Reiterated by HC Wainwright
marketbeat.com - March 24 at 8:22 AM
finanznachrichten.de logoInnate Pharma SA: Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update
finanznachrichten.de - March 23 at 8:25 AM
marketbeat.com logoInnate Pharma (IPHA) Scheduled to Post Quarterly Earnings on Thursday
marketbeat.com - March 17 at 9:39 AM
seekingalpha.com logoIPHA Innate Pharma S.A.
seekingalpha.com - February 17 at 11:07 PM
finance.yahoo.com logoAfter Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs
finance.yahoo.com - December 19 at 1:01 PM
markets.businessinsider.com logoSanofi, Innate Expand Collaboration For Natural Killer Cell Therapeutics In Oncology
markets.businessinsider.com - December 19 at 8:00 AM
finance.yahoo.com logoSanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
finance.yahoo.com - December 19 at 8:00 AM
marketbeat.com logoFY2022 EPS Estimates for Innate Pharma S.A. Decreased by Analyst (NASDAQ:IPHA)
marketbeat.com - November 21 at 1:30 AM
marketbeat.com logoFY2025 Earnings Forecast for Innate Pharma S.A. Issued By HC Wainwright (NASDAQ:IPHA)
marketbeat.com - November 18 at 8:06 AM
marketbeat.com logoSVB Leerink Comments on Innate Pharma S.A.'s FY2022 Earnings (NASDAQ:IPHA)
marketbeat.com - November 18 at 6:40 AM
marketbeat.com logoInnate Pharma S.A. (NASDAQ:IPHA) Short Interest Up 12.8% in October
marketbeat.com - November 16 at 4:21 PM
marketbeat.com logoSVB Leerink Cuts Innate Pharma (NASDAQ:IPHA) Price Target to $9.00
marketbeat.com - November 15 at 8:19 AM
seekingalpha.com logoInnate Pharma S.A. (IPHA) Q3 2022 Earnings Call Transcript
seekingalpha.com - November 14 at 9:16 PM
marketbeat.com logoInnate Pharma (IPHA) Set to Announce Quarterly Earnings on Monday
marketbeat.com - November 8 at 8:42 AM
finance.yahoo.com logoInnate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
finance.yahoo.com - November 4 at 3:37 AM
marketbeat.com logoInnate Pharma S.A. (NASDAQ:IPHA) Sees Significant Growth in Short Interest
marketbeat.com - October 29 at 7:26 PM
Get Innate Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for IPHA and its competitors with MarketBeat's FREE daily newsletter.

Laser breakthrough could send stock soaring 2,467% (Ad)

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

Here's the next stock we think soars >>>

IPHA Media Mentions By Week

IPHA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IPHA
News Sentiment

0.00

0.43

Average
Medical
News Sentiment

IPHA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IPHA Articles
This Week

1

0

IPHA Articles
Average Week

Get Innate Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for IPHA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:IPHA) was last updated on 2/24/2024 by MarketBeat.com Staff

From Our Partners